Cargando…

The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up

PURPOSE: Parameniscal cysts are associate with horizontal meniscal tears. Arthroscopic meniscal repair and the excision of the cyst by mini-open approach represent a valid treatment. However, the recurrence of cyst is still a current issue. Therefore, biological factors may be considered to promote...

Descripción completa

Detalles Bibliográficos
Autores principales: Screpis, Daniele, Piovan, Gianluca, Natali, Simone, Pasqualotto, Stefano, Magnanelli, Stefano, Iacono, Venanzio, Farinelli, Luca, Grassi, Marco, Zorzi, Claudio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633331/
https://www.ncbi.nlm.nih.gov/pubmed/34846594
http://dx.doi.org/10.1186/s40634-021-00423-1
_version_ 1784607905484374016
author Screpis, Daniele
Piovan, Gianluca
Natali, Simone
Pasqualotto, Stefano
Magnanelli, Stefano
Iacono, Venanzio
Farinelli, Luca
Grassi, Marco
Zorzi, Claudio
author_facet Screpis, Daniele
Piovan, Gianluca
Natali, Simone
Pasqualotto, Stefano
Magnanelli, Stefano
Iacono, Venanzio
Farinelli, Luca
Grassi, Marco
Zorzi, Claudio
author_sort Screpis, Daniele
collection PubMed
description PURPOSE: Parameniscal cysts are associate with horizontal meniscal tears. Arthroscopic meniscal repair and the excision of the cyst by mini-open approach represent a valid treatment. However, the recurrence of cyst is still a current issue. Therefore, biological factors may be considered to promote the biological repair and avoid recurrence. The aim of the present study was to report the clinical results and the rate of recurrence of the cyst after minimum 2-year of follow up in a cohort of patients treated by meniscal repair and autologous platelet-rich fibrin matrix augment. METHODS: Patients with lateral parameniscal cyst undergoing arthroscopic meniscal repair and autologous platelet-rich fibrin matrix augment between 2016 and 2019 were retrospectively reviewed in March 2021. Inclusion criteria were absence of prior surgery on the affected knee with minimum 2-year of follow-up. Exclusion criteria were concomitant ligament lesions, rheumatic diseases and knee osteoarthritis. After reviewing the database, each selected patient was contacted and asked to participate in the study; at the follow-up evaluation all patient signed an informed consent. Tegner-Lysholm knee score, IKDC and NRS were collected before surgery and at follow-up. RESULTS: This study included 15 patients (8 male) with mean age of 32.8 years old. No recurrence of the cysts was observed. The Tegner-Lysholm knee score and IKDC subjective scores increased respectively from 41.3 ± 5.4 and 37.6 ± 5.1 at baseline to 92.3 ± 4.6 and 89.4 ± 2.6 at the final follow up. Concerning pain relief, the Numeric Pain Rating Scale (NRS) displayed a significant improvement reaching at the follow up a score of 1,3 ± 1.1 in comparison to 6.8 ± 0.9 at the baseline. CONCLUSION: Surgical management of symptomatic lateral parameniscal cyst with cyst excision, autologous PRP membrane application and meniscus repair demonstrated excellent subjective clinical outcome with any cyst reoccurrence. LEVEL OF EVIDENCE: III, retrospective cohort study.
format Online
Article
Text
id pubmed-8633331
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-86333312021-12-15 The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up Screpis, Daniele Piovan, Gianluca Natali, Simone Pasqualotto, Stefano Magnanelli, Stefano Iacono, Venanzio Farinelli, Luca Grassi, Marco Zorzi, Claudio J Exp Orthop Original Paper PURPOSE: Parameniscal cysts are associate with horizontal meniscal tears. Arthroscopic meniscal repair and the excision of the cyst by mini-open approach represent a valid treatment. However, the recurrence of cyst is still a current issue. Therefore, biological factors may be considered to promote the biological repair and avoid recurrence. The aim of the present study was to report the clinical results and the rate of recurrence of the cyst after minimum 2-year of follow up in a cohort of patients treated by meniscal repair and autologous platelet-rich fibrin matrix augment. METHODS: Patients with lateral parameniscal cyst undergoing arthroscopic meniscal repair and autologous platelet-rich fibrin matrix augment between 2016 and 2019 were retrospectively reviewed in March 2021. Inclusion criteria were absence of prior surgery on the affected knee with minimum 2-year of follow-up. Exclusion criteria were concomitant ligament lesions, rheumatic diseases and knee osteoarthritis. After reviewing the database, each selected patient was contacted and asked to participate in the study; at the follow-up evaluation all patient signed an informed consent. Tegner-Lysholm knee score, IKDC and NRS were collected before surgery and at follow-up. RESULTS: This study included 15 patients (8 male) with mean age of 32.8 years old. No recurrence of the cysts was observed. The Tegner-Lysholm knee score and IKDC subjective scores increased respectively from 41.3 ± 5.4 and 37.6 ± 5.1 at baseline to 92.3 ± 4.6 and 89.4 ± 2.6 at the final follow up. Concerning pain relief, the Numeric Pain Rating Scale (NRS) displayed a significant improvement reaching at the follow up a score of 1,3 ± 1.1 in comparison to 6.8 ± 0.9 at the baseline. CONCLUSION: Surgical management of symptomatic lateral parameniscal cyst with cyst excision, autologous PRP membrane application and meniscus repair demonstrated excellent subjective clinical outcome with any cyst reoccurrence. LEVEL OF EVIDENCE: III, retrospective cohort study. Springer Berlin Heidelberg 2021-11-30 /pmc/articles/PMC8633331/ /pubmed/34846594 http://dx.doi.org/10.1186/s40634-021-00423-1 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Original Paper
Screpis, Daniele
Piovan, Gianluca
Natali, Simone
Pasqualotto, Stefano
Magnanelli, Stefano
Iacono, Venanzio
Farinelli, Luca
Grassi, Marco
Zorzi, Claudio
The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_full The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_fullStr The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_full_unstemmed The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_short The use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
title_sort use of autologous platelet-rich fibrin matrix combined with meniscal repair in the treatment of parameniscal cyst: clinical results and cyst recurrence after 2-year of follow up
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8633331/
https://www.ncbi.nlm.nih.gov/pubmed/34846594
http://dx.doi.org/10.1186/s40634-021-00423-1
work_keys_str_mv AT screpisdaniele theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT piovangianluca theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT natalisimone theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT pasqualottostefano theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT magnanellistefano theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT iaconovenanzio theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT farinelliluca theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT grassimarco theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT zorziclaudio theuseofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT screpisdaniele useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT piovangianluca useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT natalisimone useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT pasqualottostefano useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT magnanellistefano useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT iaconovenanzio useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT farinelliluca useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT grassimarco useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup
AT zorziclaudio useofautologousplateletrichfibrinmatrixcombinedwithmeniscalrepairinthetreatmentofparameniscalcystclinicalresultsandcystrecurrenceafter2yearoffollowup